drugset / Trial / NCT02094703
The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females
Phase 4
Unknown
126 enrolled
Dr Cipto Mangunkusumo General Hospital
Astellas Pharma Indonesia Inc. · collabPharos Life Corporation · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The efficacy of Solifenacin Succinate 5 mg as adjuvant therapy and levofloxacin (500 mg) for short-term treatment to reduce symptoms in patients with symptomatic non complicated urinary tract infection in females.
Timeline
- Start
- 2013-04
- Primary completion
- 2014-11
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Solifenacin | Small molecule | 5 mg | Oral |
| Background | Levofloxacin | Small molecule | 500 mg | Oral |